Biomarker Research for Personalized Medicine

Inje University

Status: Unknown

Conditions: Hematologic Neoplasms

Study type: Observational

Funder types: Other

Identifiers

NCT01488591

09-029

Details and patient eligibility

About

The aim of this study :

1. Through the study of genes of protein, transporter, translator and epigenome investigating the effect of anti-cancer treatment or the key factor of the MDR (Multidrug resistance) on the blood cancer patients who are under the anti-cancer sork treatment
2. Giving a service of anticancer medicine therapeutic drug monitoring (TDM) and genotyping

Enrollment: 1,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Korean
• Clinical diagnosis of Hematologic neoplasms